Duration of clopidogrel treatment and risk of mortality and recurrent myocardial infarction among 11 680 patients with myocardial infarction treated with percutaneous coronary intervention: a cohort study

BACKGROUND: The optimal duration of clopidogrel treatment after percutaneous coronary intervention (PCI) is unclear. We studied the risk of death or recurrent myocardial infarction (MI) in relation to 6- and 12-months clopidogrel treatment among MI patients treated with PCI. METHODS: Using nationwid...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Sørensen, Rikke, Abildstrom, Steen Z, Weeke, Peter, Fosbøl, Emil L, Folke, Fredrik, Hansen, Morten L, Hansen, Peter R, Madsen, Jan K, Abildgaard, Ulrik, Køber, Lars, Poulsen, Henrik E, Torp-Pedersen, Christian, Gislason, Gunnar H
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2010
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2837608/
https://ncbi.nlm.nih.gov/pubmed/20113477
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2261-10-6
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller